Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Cognetivity Neurosciences Ltd.

Market Cap 1.2M 854K 737K 678K 638K 80.63M 1.21M 8.03M 3.13M 39.57M 3.21M 3.14M 137M P/E 2022
-2.9x
P/E 2023 -2.8x
Enterprise Value 245K 175K 151K 139K 130K 16.49M 247K 1.64M 640K 8.1M 656K 642K 28M EV / Sales 2022
-
EV / Sales 2023 437,922,999x
Free-Float
85.56%
Yield 2022 *
-
Yield 2023 -
Manager TitleAgeSince
Chief Executive Officer 45 01/04/2013
Compliance Officer 67 21/12/2017
Director TitleAgeSince
Director/Board Member 45 01/01/2017
Director/Board Member 67 21/12/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-33.33% - - 9.36K
-5.22%-5.44%-45.07%-22.59% 25.15B
-0.76%+2.96%-39.44%+144.72% 12.47B
-2.99%-8.87%-13.01%+47.59% 5.82B
+2.46%+11.59% - - 2.83B
-3.51%+0.84%+35.14%-46.30% 1.75B
+3.74%+5.40% - - 1.78B
+2.47%+4.10%-28.61% - 1.28B
-2.53%-4.93%-36.10%-60.48% 795M
-1.09%-2.72%-32.71%+217.92% 767M
Average -0.27%+0.11%-22.83%+46.81% 5.85B
Weighted average by Cap. -0.62%-1.83%-36.01%+33.19%

Financials

2022 2023
Net sales - 0.05 0.03 0.03 0.03 0.02 3.05 0.05 0.3 0.12 1.5 0.12 0.12 5.18
Net income -13.13M -9.36M -8.07M -7.42M -6.99M -883M -13.24M -87.96M -34.24M -433M -35.12M -34.37M -1.5B -7.43M -5.3M -4.57M -4.2M -3.96M -500M -7.5M -49.81M -19.39M -245M -19.89M -19.46M -849M
Net Debt -82.43K -58.76K -50.69K -46.61K -43.87K -5.55M -83.12K -552K -215K -2.72M -221K -216K -9.42M -953K -680K -586K -539K -507K -64.14M -961K -6.39M -2.49M -31.48M -2.55M -2.5M -109M
Logo Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!